1-3 of 3
Kaoutar Hafraoui, MD
Close
Sort by
Journal Articles

Long-Term Safety Follow-up of a Randomized Trial of Darbepoetin Alpha and Intravenous Iron Following Autologous Hematopoietic Cell Transplantation

Aurélie Jaspers, MD, Frederic Baron, MD PhD, Johan Maertens, MD PhD, Bernard J. M. De Prijck, MD, Henri (Rik) Schots, MDPhD, Christophe Bonnet, MD PhD, Kaoutar Hafraoui, MD, Evelyne Willems, MD PhD, Sophie Servais, MD PhD, Georges Fillet, MD PhD, Yves Beguin, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3948.
https://doi.org/10.1182/blood.V124.21.3948.3948
Published: 2014
Journal Articles

Nonmyeloablative Stem Cell Transplantation with CD8-Depleted or Unmanipulated Peripheral Blood Stem Cells: A Prospective Randomized Trial.

Evelyne Willems, MD, Emilie Castermans, Frédéric Baron, MD, PhD, Etienne Baudoux, MD, Nadine Wanten, Christophe Bonnet, MD, Kaoutar Hafraoui, MD, Pascale Frère, MD, Georges Fillet, MD, PhD, Yves Beguin, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1075.
https://doi.org/10.1182/blood.V106.11.1075.1075
Published: 2005
Journal Articles

Infections after Allogeneic Hematopoietic Stem Cell Transplantation with a Nonmyeloablative Conditioning Regimen.

Pascale Frère, MD, Frédéric Baron, MD, Christoffe Bonnet, MD, Kaoutar Hafraoui, MD, Maguy Pereira, RN, Evelyne Willems, MD, Georges Fillet, MD, PhD, Yves Beguin, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 5086.
https://doi.org/10.1182/blood.V104.11.5086.5086
Published: 2004